Tomeglovir is primarily utilized in the field of antiviral research and therapy. It has shown potential in targeting and inhibiting the replication of certain viruses, making it a candidate for the development of antiviral medications. Specifically, its application is being explored in the treatment of viral infections where traditional antiviral agents may be less effective. Researchers are investigating its efficacy in reducing viral load and managing symptoms in preclinical and clinical studies. Additionally, Tomeglovir is being studied for its potential use in combination therapies to enhance the overall effectiveness of antiviral treatments. Its role in combating drug-resistant viral strains is also a significant area of interest, offering hope for improved therapeutic options in the future.